Gujarat Themis Biosyn begins commercial operations at new API plant in Vapi
May 06, 2025
Valsad: Gujarat Themis Biosyn Ltd. has begun commercial operations at its newly built Active Pharmaceutical Ingredient (API) manufacturing unit in Vapi GIDC.
The company, in a regulatory filing to stock exchanges, said, “We are pleased to inform you that today i.e. 6 May, 2025, the Company has commenced its commercial production at its newly set up API Plant situated at 69/C, GIDC Industrial Estate, Vapi-396195, Dist. Valsad, Gujarat, India.”
“This state-of-the-art, multi-purpose synthetic and fermentation-based API plant has been established for the production of various Active Pharmaceutical Ingredients (APIs) and Intermediates for use in the pharmaceutical industry. The facility will support the Company’s forward integration initiatives and strengthen its position in export markets, particularly in the United States and Europe,” the filing further said. DeshGujarat
Recent Stories
- HDFC Bank Gets Govt Nod to Offer Deposits Under Capital Gains Accounts Scheme
- GSSSB Announces Recruitment for 1,237 Class-3 Posts; Applications Open on November 5
- AMC to Hike Parking Fees; Proposed New Rates Here
- Mumbai Mayor Ritu Tawde Meets Gujarat CM Bhupendra Patel
- Holiday Inn Resort to Come Up in Sasan Gir
- Lemon Tree Hotels Opens New Resort in Pavagadh